Picture of Venus Remedies logo

VENUSREM Venus Remedies Income Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapContrarian

Annual income statement for Venus Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2018
March 31st
2019
March 31st
C2020
March 31st
2021
March 31st
2022
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue3,7243,2193,3935,4815,986
Cost of Revenue
Gross Profit1,6731,3991,6502,0732,132
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses3,6683,3233,3935,0625,696
Operating Profit56.4-104-0.058419290
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-275-297-80.4486364
Provision for Income Taxes
Net Income After Taxes-307-286-100618407
Net Income Before Extraordinary Items
Net Income-307-286-100618407
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-307-286-100618407
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-24.9-18.4-3.4637.730.9
Dividends per Share

Or unlock with your email

Or unlock with your email